CN1291992A - 结合到hla－a29分子上的分离的多肽,编码它们的分子－核酸及其应用 - Google Patents

结合到hla－a29分子上的分离的多肽,编码它们的分子－核酸及其应用 Download PDF

Info

Publication number
CN1291992A
CN1291992A CN99803245A CN99803245A CN1291992A CN 1291992 A CN1291992 A CN 1291992A CN 99803245 A CN99803245 A CN 99803245A CN 99803245 A CN99803245 A CN 99803245A CN 1291992 A CN1291992 A CN 1291992A
Authority
CN
China
Prior art keywords
seq
cell
hla
peptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99803245A
Other languages
English (en)
Chinese (zh)
Inventor
皮埃尔·范德布鲁根
贝努特·范登艾恩德
奥利维尔·德贝克
西里·布恩－法勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research New York
Publication of CN1291992A publication Critical patent/CN1291992A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN99803245A 1998-01-23 1999-01-12 结合到hla－a29分子上的分离的多肽,编码它们的分子－核酸及其应用 Pending CN1291992A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1281898A 1998-01-23 1998-01-23
US09/012,818 1998-01-23

Publications (1)

Publication Number Publication Date
CN1291992A true CN1291992A (zh) 2001-04-18

Family

ID=21756847

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99803245A Pending CN1291992A (zh) 1998-01-23 1999-01-12 结合到hla－a29分子上的分离的多肽,编码它们的分子－核酸及其应用

Country Status (8)

Country Link
EP (1) EP1047707A1 (fr)
JP (1) JP2002509859A (fr)
KR (1) KR20010024877A (fr)
CN (1) CN1291992A (fr)
AU (1) AU2318999A (fr)
CA (1) CA2317492A1 (fr)
WO (1) WO1999037665A1 (fr)
ZA (1) ZA99445B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001229681A1 (en) * 2000-01-20 2001-07-31 Ludwig Institute For Cancer Research Mage antigenic peptides which bind hla-b35 and hla-b44
JP2003529350A (ja) * 2000-02-15 2003-10-07 キュラジェン コーポレイション ポリペプチドおよびそれをコードする核酸
EP1605045A3 (fr) * 2000-02-15 2006-03-01 Curagen Corporation Polypeptides et acides nucléiques les codant
US6506875B1 (en) * 2000-09-26 2003-01-14 Ludwig Institute For Cancer Research Isolated peptides which bind to HLA-C molecules and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858689A (en) * 1993-07-22 1999-01-12 Ludwig Institute For Cancer Research Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
US5877155A (en) * 1995-03-17 1999-03-02 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX

Also Published As

Publication number Publication date
CA2317492A1 (fr) 1999-07-29
KR20010024877A (ko) 2001-03-26
ZA99445B (en) 1999-07-21
AU2318999A (en) 1999-08-09
WO1999037665A1 (fr) 1999-07-29
JP2002509859A (ja) 2002-04-02
EP1047707A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
CN1093751A (zh) 编码肿瘤排斥抗原前体mage-3及其应用
CN1175954A (zh) 由hla分子提呈的分离的九肽及其应用
CN1149257A (zh) 分离的肿瘤排斥抗原前体mage-2衍生的肽及其应用
CN1110503C (zh) 编码gage肿瘤排斥抗原的分离的截短的核酸分子
CN1169966C (zh) 酪氨酸酶衍生的分离肽及其应用
CN1209876A (zh) 分离的酪氨酸酶衍生肽及其应用
CN1324404A (zh) 新型肿瘤抗原蛋白sart－3及其肿瘤抗原肽
CN1291992A (zh) 结合到hla－a29分子上的分离的多肽,编码它们的分子－核酸及其应用
CN1223689A (zh) 脑糖原磷酸化酶癌症抗原
CN1179180A (zh) Rage肿瘤排斥抗原
CN1300827A (zh) 一种新的多肽—人水手转座酶19和编码这种多肽的多核苷酸
CN1342664A (zh) 一种新的多肽——含WD重复域的G－beta蛋白14.08和编码这种多肽的多核苷酸
CN1338472A (zh) 一种新的多肽——人锌指蛋白75.68和编码这种多肽的多核苷酸
CN1376679A (zh) 一种多肽——锚蛋白相似蛋白－77.77和编码这种多肽的多核苷酸
CN1380336A (zh) 一种多肽——锌指蛋白－9.13和编码这种多肽的多核苷酸
CN1386755A (zh) 一种多肽——糖蛋白－11.22和编码这种多肽的多核苷酸
CN1393549A (zh) 一种多肽——胰蛋白酶原－26.51和编码这种多肽的多核苷酸
CN1380313A (zh) 一种多肽——zp1受体蛋白－37.95和编码这种多肽的多核苷酸
CN1359911A (zh) 一种新的多肽——铁调节蛋白38.39和编码这种多肽的多核苷酸
CN1300767A (zh) 一种新的多肽－锌指蛋白30和编码这种多肽的多核苷酸
CN1381468A (zh) 一种多肽——人红细胞胞质蛋白－8.8和编码这种多肽的多核苷酸
CN1376707A (zh) 一种多肽——人锌指蛋白－35.09和编码这种多肽的多核苷酸
CN1380311A (zh) 一种多肽——组蛋白h3－9.35和编码这种多肽的多核苷酸
CN1380321A (zh) 一种多肽——锌指蛋白－59.18和编码这种多肽的多核苷酸
CN1343678A (zh) 一种新的多肽——含结合蛋白依赖转运系统的蛋白质11.77和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1033141

Country of ref document: HK